Proshares Ultrashort HealthETF
13F holders, Q2 2024 (June 30)2holders −1
0new positions
1sold out
$10.49avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Proshares Ultrashort Health in their 13F filings, down 1 from Q1 2024. 0 opened new positions and 1 sold out. The largest holders were UBS Group AG ($37K) and Morgan Stanley ($17).
- Company
- Proshares Ultrashort Health
- CUSIP
- 74347G564
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $248K |
All 13F filers, Q1 2024 → Q2 2024: 25,162 shares sold, net −25,162 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| UBS Group AG | 0.00% | Reduce -18.5% | 3,538 | $37K |
| Morgan Stanley | 0.00% | No change | 1 | $17 |
"% of holder's portfolio" is PROSHARES ULTRASHORT HEALTH's weight in each manager's 13F, not the share of Proshares Ultrashort Health the manager owns.